Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Follicular 7Lymphoma, B-Cell, Marginal Zone 7Breast Neoplasms 7Lymphoma, Non-Hodgkin 6Lymphoma, Mantle-Cell 6Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myeloid, Acute 5Leukemia, Lymphocytic, Chronic, B-Cell 5Leukemia 5Congenital Abnormalities 5Carcinoma, Ovarian Epithelial 5Waldenstrom Macroglobulinemia 4Lymphoma, Large-Cell, Immunoblastic 4Burkitt Lymphoma 4Myelodysplastic Syndromes 3Melanoma 3Lung Neoplasms 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Accelerated Phase 3Carcinoma, Non-Small-Cell Lung 3Blast Crisis 3Wilms Tumor 2Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Testicular Neoplasms 2Stomach Neoplasms 2Sezary Syndrome 2Recurrence 2Prostatic Neoplasms 2

Interventions

Cisplatin 21Etoposide 20Carboplatin 20Topotecan 13pembrolizumab 12durvalumab 11Paclitaxel 10Irinotecan 9Nivolumab 7Gemcitabine 7tremelimumab 6atezolizumab 6Radiotherapy 6Docetaxel 6Pemetrexed 5Ipilimumab 5Cyclophosphamide 5rovalpituzumab tesirine 4budigalimab 4Specimen Handling 4Injections 4Doxorubicin 4Bortezomib 4130-nm albumin-bound paclitaxel 4venetoclax 3talazoparib 3olaparib 3fludarabine 3etoposide phosphate 3Platinum 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Small Cell Lung Carcinoma × Flow Cytometry × Clear all
NCT00388089 2010-06-29

Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors

University of California, Davis

Phase 1 Completed
24 enrolled
Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡